BOLIGNANO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 5.085
AS - Asia 3.072
EU - Europa 1.274
SA - Sud America 689
Continente sconosciuto - Info sul continente non disponibili 283
AF - Africa 103
OC - Oceania 8
AN - Antartide 1
Totale 10.515
Nazione #
US - Stati Uniti d'America 4.814
SG - Singapore 1.369
CN - Cina 671
IT - Italia 578
BR - Brasile 542
VN - Vietnam 317
IN - India 281
CA - Canada 174
DE - Germania 148
SE - Svezia 145
HK - Hong Kong 143
BD - Bangladesh 106
GB - Regno Unito 97
FI - Finlandia 63
AR - Argentina 56
NL - Olanda 45
MX - Messico 34
RU - Federazione Russa 30
ID - Indonesia 29
FR - Francia 27
RO - Romania 27
EC - Ecuador 26
ES - Italia 24
IQ - Iraq 22
PL - Polonia 22
CL - Cile 21
JP - Giappone 20
ZA - Sudafrica 20
UA - Ucraina 18
EG - Egitto 16
CO - Colombia 14
MA - Marocco 13
PK - Pakistan 13
TR - Turchia 13
IR - Iran 12
TN - Tunisia 11
VE - Venezuela 11
AT - Austria 10
CR - Costa Rica 9
IL - Israele 9
UZ - Uzbekistan 9
GT - Guatemala 8
HN - Honduras 8
KE - Kenya 8
PY - Paraguay 8
SA - Arabia Saudita 8
SV - El Salvador 8
AU - Australia 7
JO - Giordania 7
PE - Perù 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
JM - Giamaica 6
SN - Senegal 6
TH - Thailandia 6
TW - Taiwan 6
LT - Lituania 5
NG - Nigeria 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
KG - Kirghizistan 4
KZ - Kazakistan 4
MK - Macedonia 4
SC - Seychelles 4
AO - Angola 3
AZ - Azerbaigian 3
BB - Barbados 3
BG - Bulgaria 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
GR - Grecia 3
PA - Panama 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
BE - Belgio 2
CH - Svizzera 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GP - Guadalupe 2
GY - Guiana 2
HR - Croazia 2
KR - Corea 2
LB - Libano 2
ML - Mali 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
SI - Slovenia 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AQ - Antartide 1
AW - Aruba 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
Totale 10.223
Città #
San Jose 981
Singapore 475
Ashburn 404
Dallas 389
Santa Clara 314
Council Bluffs 307
Bengaluru 222
Hefei 222
Chandler 212
Milan 196
Princeton 176
Lawrence 171
Hong Kong 139
Beijing 130
Ho Chi Minh City 122
Wilmington 118
Ottawa 106
Munich 102
Los Angeles 80
Phoenix 70
Hanoi 59
São Paulo 57
Boardman 54
New York 46
Chicago 45
London 42
Des Moines 38
Turku 38
Rome 36
Helsinki 25
Boston 24
Naples 22
Montreal 20
Rio de Janeiro 20
Warsaw 19
Amsterdam 18
Brooklyn 17
Mexico City 17
San Francisco 17
Tokyo 17
Da Nang 16
Orem 16
Chennai 15
The Dalles 15
Bari 14
Brasília 14
Atlanta 13
Catanzaro 13
Guayaquil 13
Norwalk 13
Redmond 13
Columbus 12
Johannesburg 12
Biên Hòa 11
Denver 11
Haiphong 11
Seattle 11
Timisoara 11
Crotone 10
Florence 10
Guangzhou 10
Guarulhos 10
New Delhi 10
Stockholm 10
Jakarta 9
Manchester 9
Palermo 9
Pune 9
Baghdad 8
Charlotte 8
Hải Dương 8
Ninh Bình 8
Shibin al Kawm 8
Tashkent 8
Toronto 8
Washington 8
Ankara 7
Bologna 7
Erbil 7
Guatemala City 7
Nairobi 7
Newark 7
Redwood City 7
San José 7
Santo André 7
Shanghai 7
Thái Bình 7
Ann Arbor 6
Asunción 6
Buenos Aires 6
Campinas 6
Catania 6
Cosenza 6
Dakar 6
Goiânia 6
Lima 6
Louisville 6
Miami 6
Osasco 6
Quito 6
Totale 6.116
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 135
Antecedent ACE-inhibition, inflammatory response, and cardiac surgery associated acute kidney injury 125
Hyperkalemia excursions and risk of mortality and hospitalizations in hemodialysis patients: results from DOPPS-Italy 116
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study 96
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 91
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 90
#4500 IMPLEMENTATION OF A NEW GENERATION DIGITAL STETHOSCOPE FOR ARTERIOVENOUS FISTULA MONITORING IN HEMODIALYSIS PATIENTS 89
A brief "update" on renal effects of caffeine 89
Erratum: Exercise in patients on dialysis: A multicenter, randomized clinical trial (Journal of the American Society of Nephrology (2017) 28 (1259–1268) DOI: 10.1681/ASN.2016030378) 86
A portable easy-to-use triboelectric sensor for arteriovenous fistula monitoring in dialysis patients 85
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 82
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease 81
LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS 80
Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. 80
Evaluation of arteriovenous fistula for hemodialysis with a new generation digital stethoscope: a pilot study 79
Acquisition of optical coherence tomography angiography metrics during hemodialysis procedures: A pilot study 76
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 76
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients 75
Renal denervation for resistant hypertension 74
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients 73
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study 73
#4524 TRIBOELECTRIC EVALUATION OF ARTERIOVENOUS FISTULA FOR HAEMODIALYSIS: A PILOT STUDY 72
[AVP: a new target in the treatment of chronic kidney disease?] 72
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 72
Hyperkalemia in CKD: an overview of available therapeutic strategies 71
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases 70
Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors 70
Aldosterone antagonists for preventing the progression of chronic kidney disease 69
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study 68
Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease 67
Alterations of lipid metabolism in chronic nephropathies: Mechanisms, diagnosis and treatment 66
Effects of weight loss on renal function in obese CKD patients: A systematic review 66
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 65
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 65
Development of a Wearable Device for Arteriovenous Fistula Monitoring 64
[Neutrophil gelatinase-associated lipocalin (NGAL): a biomarker beyond the confines of nephrology] 64
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide 64
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy 64
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 63
Very low urinary marinobufagenin excretion reflects a high risk of disease progression in non-advanced CKD 61
[Italian adaptation of the European Renal Best Practice (ERBP) guideline on kidney donor and recipient evaluation and perioperative care] 61
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 61
Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications 60
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients 60
Anti-seizure medications in patients with renal failure undergoing dialysis: how to manage? 60
Erythropoietin and its lost receptor 59
Aquaretic agents: What's beyond the treatment of hyponatremia? 58
Acute cardiovascular complications of hemodialysis 58
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all 58
Aquaretic-induced apoptosis: A cure or a curse? 58
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 58
Childhood Obesity: Insight into Kidney Involvement 57
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 57
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 57
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 57
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 57
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools 56
Glitazones in chronic kidney disease: Potential and concerns 56
OCT angiography metrics predict intradialytic hypotension episodes in chronic hemodialysis patients: a pilot, prospective study 56
Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease 55
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 55
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization 54
[Erythropoietin: pleiotropic actions] 54
Utility of Blood Flow/Resistance Index Ratio (Qx) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 54
Immunosuppressive Therapy, Puberty and Growth Outcomes in Pediatric Kidney Transplant Recipients: A Pragmatic Review 53
Dialysis and the Elderly: An Underestimated Problem 53
[The future of the European nephrology belongs to the young: the Young Nephrologists' Platform] 53
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Renal Function Decline in Patients With Glomerular Diseases 53
Study designs adopted in epidemiology of chronic diseases 53
Potential Pathogenetic Role of the D313Y Mutation in the GLA Gene in Anderson Fabry Disease: Two Case Reports 52
Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis 52
Oxidative stress and kidney function: a brief update 52
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 52
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 51
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the EXCITE trial 51
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 51
Caffeine and the kidney: What evidence right now? 51
Genomic damage in endothelial progenitor cells from uremic patients 51
Hypertension in kidney transplantation: a consensus statement of the 'hypertension and the kidney' working group of the European Society of Hypertension 50
Malnutrition in the elderly patient on dialysis 50
The aging kidney revisited: A systematic review 50
Neutrophil Gelatinase-associated Lipocalin in the Cardio–Renal Axis – Pathogenic Factor or Just a Risk Biomarker? 49
A new therapy for kidney injury: regeneration 49
Study designs adopted in epidemiology of chronic diseases 49
Decreased Cathepsin-K Mirrors the Severity of Subclinical Atherosclerosis in Kidney Transplant Recipients 48
Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study 48
[TNF-alpha receptors (TNFRS): the biomarkers of progressive diabetic nephropathy we were waiting for?] 48
Spice Up Your Kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease 47
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 47
Smoking habit as a risk amplifier in chronic kidney disease patients 47
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association 46
Fitness for entering a simple exercise program and mortality: a study corollary to the exercise introduction to enhance performance in dialysis (EXCITE) trial. 46
Neurobiological model and quality of life in discovering personality of the uremic patient 46
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life 46
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R) 46
Physical excercise programs in CKD: lights, shades and perspectives: a position paper of the “Physical Exercise in CKD Study Group” of the Italian Society of Nephrology 46
Good-quality research in rare diseases: trials and tribulations 46
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 46
Selenoprotein-P1 (SEPP1) Expression in Human Proximal Tubule Cells after Ischemia-Reperfusion Injury: An In Vitro Model 45
EFFECTS OF CHRONIC, LONG-TERM ACE-INHIBITOR TREATMENT ON CYTOKINE STORM AND RENAL FUNCTION AFTER CARDIO-PULMONARY BYPASS: A PROSPECTIVE OBSERVATIONAL STUDY 45
Totale 6.268
Categoria #
all - tutte 107.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022431 0 0 0 86 59 5 18 120 29 25 85 4
2022/2023869 344 99 17 38 54 43 13 55 100 28 57 21
2023/2024533 74 41 43 39 42 89 25 47 25 45 28 35
2024/20252.115 312 70 54 132 145 349 49 63 240 62 231 408
2025/20264.974 252 582 627 775 480 167 514 248 666 384 218 61
2026/20271.210 51 260 628 271 0 0 0 0 0 0 0 0
Totale 10.515